- Page 2 and 3:
The Nutritional Biochemistryof Chro
- Page 4 and 5:
The NutritionalBiochemistry ofChrom
- Page 6 and 7:
Table of ContentsPrefaceContributor
- Page 8 and 9:
PrefaceThe manufacture and sale of
- Page 10 and 11:
Prefaceixdiscuss the implications o
- Page 12 and 13:
ContributorsD. BagchiInterHealth Re
- Page 14 and 15:
Chapter 1Introduction: A history of
- Page 16 and 17:
Introduction: A history of chromium
- Page 18 and 19:
Introduction: A history of chromium
- Page 20 and 21:
Introduction: A history of chromium
- Page 22 and 23:
Introduction: A history of chromium
- Page 24 and 25:
Introduction: A history of chromium
- Page 26 and 27:
Introduction: A history of chromium
- Page 28 and 29:
Introduction: A history of chromium
- Page 30 and 31:
Introduction: A history of chromium
- Page 32 and 33:
Introduction: A history of chromium
- Page 34 and 35:
Introduction: A history of chromium
- Page 36 and 37:
Introduction: A history of chromium
- Page 38 and 39:
Introduction: A history of chromium
- Page 40 and 41:
Introduction: A history of chromium
- Page 42 and 43:
Introduction: A history of chromium
- Page 44 and 45:
Introduction: A history of chromium
- Page 46 and 47:
Introduction: A history of chromium
- Page 48 and 49:
Introduction: A history of chromium
- Page 50 and 51:
Introduction: A history of chromium
- Page 52 and 53:
Introduction: A history of chromium
- Page 54 and 55:
Part IChromium as a nutrient and nu
- Page 56:
Chapter 2Basis for dietary recommen
- Page 59 and 60:
46 Barbara J. Stoeckerof supplement
- Page 61 and 62:
48 Barbara J. StoeckerREPORTED CHRO
- Page 63 and 64:
50 Barbara J. Stoeckerhigh fiber di
- Page 65 and 66:
52 Barbara J. StoeckerEFFECTS OF ME
- Page 67 and 68:
54 Barbara J. Stoecker[26] Mohameds
- Page 69 and 70:
This page intentionally left blank
- Page 71 and 72:
58 Diane M. Stearnsabout his intell
- Page 73 and 74:
60 Diane M. StearnsMertz and cowork
- Page 75 and 76:
62 Diane M. StearnsCr 6+ or Cr 3+ r
- Page 77 and 78:
64 Diane M. Stearnsdiabetes [68-71]
- Page 79 and 80:
66 Diane M. Stearns[4] Boynton, H.,
- Page 81 and 82:
68 Diane M. Stearns[49] Vincent, J.
- Page 83 and 84:
70 Diane M. Stearns[89] Snow, E. T.
- Page 85 and 86:
72 Henry C. LukaskiThis chapter cri
- Page 87 and 88:
74 Henry C. Lukaski(1.8% vs 0.9 kg)
- Page 89 and 90:
76 Henry C. Lukaskiexercise. These
- Page 91 and 92:
78 Henry C. Lukaskiits putative rol
- Page 93 and 94:
Table 1Effects of chromium (Cr) sup
- Page 95 and 96:
82 Henry C. LukaskiSOME RESOLUTION
- Page 97 and 98:
84 Henry C. Lukaski[27] Lefavi, R.
- Page 99 and 100:
86 Merlin D. LindemannThe feed indu
- Page 101 and 102:
88 Merlin D. LindemannSWINEIntroduc
- Page 103 and 104:
90 Merlin D. Lindemannstudy [19], a
- Page 105 and 106:
92 Merlin D. Lindemann(VT) [13] cor
- Page 107 and 108:
94 Merlin D. LindemannEffects on ca
- Page 109 and 110:
96 Merlin D. LindemannTable 3Effect
- Page 111 and 112:
98 Merlin D. Lindemanninsulin [13];
- Page 113 and 114:
100 Merlin D. Lindemannno observed
- Page 115 and 116:
102 Merlin D. LindemannChromium for
- Page 117 and 118:
104 Merlin D. LindemannA dose-respo
- Page 119 and 120:
106 Merlin D. LindemannTable 5Effec
- Page 121 and 122:
108 Merlin D. LindemannSHEEPIntrodu
- Page 123 and 124:
110 Merlin D. Lindemannwere not sta
- Page 125 and 126:
112 Merlin D. Lindemann[6] National
- Page 127 and 128:
114 Merlin D. Lindemann[41] Gundel,
- Page 129 and 130:
116 Merlin D. Lindemann[75] Kegley,
- Page 131 and 132:
118 Merlin D. Lindemann[113] Xianli
- Page 133 and 134:
This page intentionally left blank
- Page 135 and 136:
122 Weiyue FengTable 1Absorption of
- Page 137 and 138:
124 Weiyue Fengto transferrin and t
- Page 139 and 140:
126 Weiyue FengKd = [Cr 51 in LMWCr
- Page 141 and 142:
128 Weiyue Fengdistribution in anim
- Page 143 and 144:
130 Weiyue FengEXCRETIONAbsorbed ch
- Page 145 and 146: 132 Weiyue FengApochromodulinApochr
- Page 147 and 148: 134 Weiyue Feng[7] Gargas, M. L., N
- Page 149 and 150: 136 Weiyue Feng[48] Vincent, J. B.
- Page 151 and 152: This page intentionally left blank
- Page 153 and 154: 140 John B. Vincent and Randall Ben
- Page 155 and 156: 142 John B. Vincent and Randall Ben
- Page 157 and 158: 144 John B. Vincent and Randall Ben
- Page 159 and 160: 146 John B. Vincent and Randall Ben
- Page 161 and 162: 148 John B. Vincent and Randall Ben
- Page 163 and 164: 150 John B. Vincent and Randall Ben
- Page 165 and 166: 152 John B. Vincent and Randall Ben
- Page 167 and 168: 154 John B. Vincent and Randall Ben
- Page 169 and 170: 156 John B. Vincent and Randall Ben
- Page 171 and 172: 158 John B. Vincent and Randall Ben
- Page 173 and 174: 160 John B. Vincent and Randall Ben
- Page 175 and 176: This page intentionally left blank
- Page 177 and 178: 164 William T. Cefaluinsulin requir
- Page 179 and 180: Table 1(Continued)ReferenceStudytyp
- Page 181 and 182: 168 William T. Cefalu160Fasting ins
- Page 183 and 184: 170 William T. Cefalurisk factors f
- Page 185 and 186: 172 William T. CefaluMeta-analysis
- Page 187 and 188: 174 William T. CefaluMinority ethni
- Page 189 and 190: 176 William T. Cefalurelate to insu
- Page 191 and 192: 178 William T. Cefalu[24] Jovanovic
- Page 193 and 194: 180 William T. Cefalu[60] Ford, E.
- Page 195: This page intentionally left blank
- Page 199 and 200: 186 S. Zafra-Stone et al.testes, an
- Page 201 and 202: 188 S. Zafra-Stone et al.impeding t
- Page 203 and 204: 190 S. Zafra-Stone et al.180160140G
- Page 205 and 206: 192 S. Zafra-Stone et al.with eleva
- Page 207 and 208: 194 S. Zafra-Stone et al.fed a diet
- Page 209 and 210: 196 S. Zafra-Stone et al.1.14 ± 0.
- Page 211 and 212: 198 S. Zafra-Stone et al.Grant et a
- Page 213 and 214: 200 S. Zafra-Stone et al.difference
- Page 215 and 216: 202 S. Zafra-Stone et al.regulating
- Page 217 and 218: 204 S. Zafra-Stone et al.[32] Shind
- Page 219 and 220: 206 S. Zafra-Stone et al.[66] Pasma
- Page 221 and 222: This page intentionally left blank
- Page 223 and 224: 210 Diane M. Stearnsthe FDA does ha
- Page 225 and 226: 212 Diane M. StearnsConference on H
- Page 227 and 228: 214 Diane M. StearnsTHE IN VITRO MO
- Page 229 and 230: 216 Diane M. Stearnsrelevant form o
- Page 231 and 232: 218 Diane M. Stearnsmutant colonies
- Page 233 and 234: 220 Diane M. Stearns[15] Bright, P.
- Page 235 and 236: 222 Diane M. Stearns[58] Gee, P., M
- Page 237 and 238: 224 Diane M. Stearns[96] Parand, A.
- Page 239 and 240: 226 Aviva Levina et al.FORMATION AN
- Page 241 and 242: 228 Aviva Levina et al.PhagocytesO
- Page 243 and 244: 230 Aviva Levina et al.serum produc
- Page 245 and 246: 232 Aviva Levina et al.evidence for
- Page 247 and 248:
234 Aviva Levina et al.of Cr(III) c
- Page 249 and 250:
236 Aviva Levina et al.a preconcept
- Page 251 and 252:
238 Aviva Levina et al.oxo-carboxyl
- Page 253 and 254:
240 Aviva Levina et al.radicals 17,
- Page 255 and 256:
242 Aviva Levina et al.(formed in t
- Page 257 and 258:
244 Aviva Levina et al.improve gluc
- Page 259 and 260:
246 Aviva Levina et al.The oxidativ
- Page 261 and 262:
248 Aviva Levina et al.[31] Levina,
- Page 263 and 264:
250 Aviva Levina et al.[69] Weeks,
- Page 265 and 266:
252 Aviva Levina et al.[105] Stearn
- Page 267 and 268:
254 Aviva Levina et al.[140] Zhang,
- Page 269 and 270:
256 Aviva Levina et al.[178] Wongse
- Page 271 and 272:
258 Qingdong Ke and Max CostaAlthou
- Page 273 and 274:
260 Qingdong Ke and Max Costafound
- Page 275 and 276:
262 Qingdong Ke and Max Costa[9] Zh
- Page 277 and 278:
This page intentionally left blank
- Page 279 and 280:
266 Forrest H. Nielsenprogram [7].
- Page 281 and 282:
268 Forrest H. NielsenThe assumed c
- Page 283 and 284:
270 Forrest H. Nielsenevidence exis
- Page 285 and 286:
272 Forrest H. Nielsenthe pharmacol
- Page 287 and 288:
274 Forrest H. NielsenA single acut
- Page 289 and 290:
276 Forrest H. Nielsen[5] Jeejeebho
- Page 291 and 292:
278 IndexChromium intakes in pregna
- Page 293:
This page intentionally left blank